Companies / Biocryst Pharmaceuticals Inc / Activity

Activity — Biocryst Pharmaceuticals Inc

14 moves.

Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
InsidersInstitutions
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon stock$2.35M+246K
246,477
0.10% of shares
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
NewCommon stock$1.77M+186K
186,125
0.07% of shares
low
Q1 2026
as of
Marble Bar Asset Management LLP
13F manager
NewCommon stock$898.6K+94K
94,388
0.04% of shares
low
Q1 2026
as of
Weiss Asset Management LP
13F manager
NewCommon stock$781.6K+82K
82,100
0.03% of shares
low
Q1 2026
as of
ALPS Advisors, Inc.
13F manager
NewCommon stock$573.6K+60K
60,250
0.02% of shares
low
Q1 2026
as of
Capital Fund Management S.A.
13F manager
NewCommon stock$544.0K+57K
57,138
0.02% of shares
low
Q4 2025
as of
Persistent Asset Partners Ltd
13F manager
NewCommon stock$403.3K+52K
51,701
0.02% of shares
low
Q2 2026
as of
RHS Financial, LLC
13F manager
NewCommon stock$190.2K+19K
19,018
<0.01% of shares
low
Q3 2025
as of
Farallon Capital Management LLC
13F manager
NewCommon stock$182.2K+24K
24,000
<0.01% of shares
low
Q1 2026
as of
Aviva PLC
13F manager
NewCommon stock$149.4K+16K
15,695
<0.01% of shares
low
Q2 2026
as of
Citizens Financial Group INC/RI
13F manager
NewCommon stock$106.5K+11K
10,649
<0.01% of shares
low
Q2 2026
as of
Pallas Capital Advisors LLC
13F manager
NewCommon stock$100.6K+10K
10,059
<0.01% of shares
low
Q1 2026
as of
Hilltop Holdings Inc.
13F manager
NewCommon stock$98.2K+10K
10,310
<0.01% of shares
low
Q4 2025
as of
Elevation Point Wealth Partners, LLC
13F manager
NewCommon stock$94.6K+12K
12,123
<0.01% of shares
low
← PrevPage 1 of 1Next →